Literature DB >> 10564586

A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization.

Y Zhang1, P Matthiesen, S Harder, R Siebert, G Castoldi, M J Calasanz, K F Wong, A Rosenwald, G Ott, N B Atkin, B Schlegelberger.   

Abstract

Deletions of the long arm of chromosome 6 (6q) are frequent chromosome aberrations in non-Hodgkin lymphomas (NHLs) and acute lymphoblastic leukemias (ALLs). It is presumed that one or more tumor suppressor genes are localized on 6q. By means of fluorescence in situ hybridization (FISH), we attempted to detect and delineate deletions of 6q in leukemias and lymphomas. We performed FISH on 148 cases of lymphoma and acute leukemia using a panel of 36 YAC probes distributed from 6q12 to 6q27 and a centromeric probe of chromosome 6 as internal control. Deletions of 6q that included a 7-cM commonly deleted region in 6q21 were detected in 59 patients who had B- and T-cell low-grade and high-grade NHL and ALL. FISH with two YAC probes flanking this region was performed on an additional 97 cases of NHL and leukemia. Deletions in 6q21 were detected in an additional 21 cases. In five cases of high-grade B- and T-cell NHL and ALL, the deletion breakpoints were located within the commonly deleted region. To define the deletion breakpoints exactly and to narrow this region further, FISH was performed with six additional YAC probes that have been physically localized within this region. A 3-cM (4-5 Mb) commonly deleted region in 6q21 was delineated. Our study suggests that this commonly deleted region harbors a putative tumor suppressor gene involved in the pathogenesis of both low-grade and high-grade NHL and ALL. Genes Chromosomes Cancer 27:52-58, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10564586     DOI: 10.1002/(sici)1098-2264(200001)27:1<52::aid-gcc7>3.0.co;2-x

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  14 in total

1.  Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.

Authors:  Andreas Zettl; Thomas Rüdiger; Maria-Anette Konrad; Andreas Chott; Ingrid Simonitsch-Klupp; Ruth Sonnen; Hans Konrad Müller-Hermelink; German Ott
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 2.  Candidate genes and potential targets for therapeutics in Wilms' tumour.

Authors:  Christopher Blackmore; Max J Coppes; Aru Narendran
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

3.  Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia.

Authors:  Rachel Sargent; Dan Jones; Lynne V Abruzzo; Hui Yao; Jaime Bonderover; Marissa Cisneros; William G Wierda; Michael J Keating; Rajyalakshmi Luthra
Journal:  J Mol Diagn       Date:  2008-12-12       Impact factor: 5.568

4.  A BEN-domain-containing protein associates with heterochromatin and represses transcription.

Authors:  Kizhakke M Sathyan; Zhen Shen; Vidisha Tripathi; Kannanganattu V Prasanth; Supriya G Prasanth
Journal:  J Cell Sci       Date:  2011-09-15       Impact factor: 5.285

5.  Consistent patterns of allelic loss in natural killer cell lymphoma.

Authors:  L L Siu; V Chan; J K Chan; K F Wong; R Liang; Y L Kwong
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

6.  HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms.

Authors:  Can Küçük; Xiaozhou Hu; Javeed Iqbal; Philippe Gaulard; David Klinkebiel; Adam Cornish; Bhavana J Dave; Wing C Chan
Journal:  Am J Pathol       Date:  2012-11-09       Impact factor: 4.307

7.  A major lung cancer susceptibility locus maps to chromosome 6q23-25.

Authors:  J E Bailey-Wilson; C I Amos; S M Pinney; G M Petersen; M de Andrade; J S Wiest; P Fain; A G Schwartz; M You; W Franklin; C Klein; A Gazdar; H Rothschild; D Mandal; T Coons; J Slusser; J Lee; C Gaba; E Kupert; A Perez; X Zhou; D Zeng; Q Liu; Q Zhang; D Seminara; J Minna; M W Anderson
Journal:  Am J Hum Genet       Date:  2004-07-21       Impact factor: 11.025

8.  RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function.

Authors:  Reza Rahbari; Mio Kitano; Lisa Zhang; Swaroop Bommareddi; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2013-02-07       Impact factor: 5.958

9.  Cyclin C is a haploinsufficient tumour suppressor.

Authors:  Na Li; Anne Fassl; Joel Chick; Hiroyuki Inuzuka; Xiaoyu Li; Marc R Mansour; Lijun Liu; Haizhen Wang; Bryan King; Shavali Shaik; Alejandro Gutierrez; Alban Ordureau; Tobias Otto; Taras Kreslavsky; Lukas Baitsch; Leah Bury; Clifford A Meyer; Nan Ke; Kristin A Mulry; Michael J Kluk; Moni Roy; Sunkyu Kim; Xiaowu Zhang; Yan Geng; Agnieszka Zagozdzon; Sarah Jenkinson; Rosemary E Gale; David C Linch; Jean J Zhao; Charles G Mullighan; J Wade Harper; Jon C Aster; Iannis Aifantis; Harald von Boehmer; Steven P Gygi; Wenyi Wei; A Thomas Look; Piotr Sicinski
Journal:  Nat Cell Biol       Date:  2014-10-26       Impact factor: 28.824

10.  TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.

Authors:  Roland Schmitz; Martin-Leo Hansmann; Verena Bohle; Jose Ignacio Martin-Subero; Sylvia Hartmann; Gunhild Mechtersheimer; Wolfram Klapper; Inga Vater; Maciej Giefing; Stefan Gesk; Jens Stanelle; Reiner Siebert; Ralf Küppers
Journal:  J Exp Med       Date:  2009-04-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.